Sceletium Extract PDE4 Inhibitor with Activity Enhancer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PDE4 inhibiting compounds have narrow therapeutic windows and often cause undesirable side effects such as nausea, diarrhea, and headaches, while there is a demand for naturally derived PDE4 inhibitors that can achieve effective PDE4 inhibition with minimal adverse effects.
Innovation Solution
A formulation comprising a Sceletium extract combined with an activity enhancer, which enhances PDE4 inhibitory activity beyond the levels achieved by either component alone, offering a synergistic effect that is more effective than additive, thereby potentially reducing side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PDE4 inhibiting compounds are administered at therapeutically effective doses, then PDE4 inhibition is achieved, but undesirable side effects such as nausea, diarrhea, and headaches occur
Solution Approach 1:
The patent changes the chemical parameters of PDE4 inhibitors by deriving them from natural sources (plants, fungi, bacteria) rather than synthetic compounds. This parameter change in the source and chemical structure allows achieving PDE4 inhibition while reducing the narrow therapeutic window and associated side effects of conventional synthetic PDE4 inhibitors
Solution Approach 2:
The patent employs composite natural-derived compounds and their combinations as PDE4 inhibitors. By using composite materials from natural sources rather than single synthetic compounds, the invention achieves therapeutic effects with improved safety profiles and reduced adverse side effects
2Adaptability or versatility
If naturally derived PDE4 inhibitors are developed, then consumer demand for natural ingredients is met, but achieving effective PDE4 inhibition with minimal side effects remains challenging
Solution Approach 1:
The patent identifies multiple natural sources (plants, fungi, bacteria) that produce PDE4 inhibiting compounds. This universality across different natural sources provides a versatile platform to meet consumer demand for natural ingredients while maintaining therapeutic effectiveness through diverse biochemical pathways
Data Source
AI summary
Phosphodiesterase-4 (PDE4) inhibiting compositions comprising a Sceletium and an activity enhancer are disclosed and described. Methods and systems for inhibiting PDE4, as well as, dosage forms comprising a Sceletium extract and an activity enhancer are also disclosed. Additionally disclosed are methods for enhancing the potency or PDE4 inhibitory activity of a Sceletium extract by addition of an activity enhancer.